flâneur — a map of the web's best reading

H1 2024 digital health funding: Resilience leads to brilliance | Rock Health

rockhealth.com · 1,659 words · saved by 1 readers

It’s been a rocky few quarters, but the digital health sector is resilient—and we’re seeing measured momentum in funding and exits to prove it. If H1’s investment pace continues, 2024 funding dollars and deal counts could exceed 2019 and 2023 historicals, two years that serve as helpful comparators outside of the pandemic-fueled funding cycle from 2020 to 2022. Early-stage checks are growing, the proportion of unlabeled deals1 is tapering, and the digital health IPO market is showing early signs of life. Meanwhile, digital innovation in healthcare continues to march forward, with AI attracting even more attention and contributing to funding patterns across product categories and therapeutic areas. Read on for our take on H1’s digital health investments, acquisitions, and public exits. In H1 2024, U.S. digital health startups raised $5.7B across 266 deals. If investment patterns continue, 2024 could exceed 2019 and 2023 year-end totals ($8.2B and $10.7B, respectively). Most of H1’s ener

H1 2024 digital health funding: Resilience leads to brilliance | Rock Health INSIGHTS Voice of the Market Adriana Krasniansky Research Mihir Somaiya Research Sari Kaganoff Chief Commercial Officer With help from: Megan Zweig Bill Evans Tiffany Marie Ramos July 8, 2024 H1 2024 digital health funding: Resilience leads to brilliance It’s been a rocky few quarters , but the digital health sector is resilient—and we’re seeing measured momentum in funding and exits to prove it. If H1’s investment pace continues, 2024 funding dollars and deal counts could exceed 2019 and 2023 historicals, two years t

Explore this link on the map →

related reading